Title: Syntheses and biological evaluation of (18)F-labeled 3-(1-benzyl-piperidin-4-yl)-1-(1-methyl-1H-indol-3-yl)propan-1-ones for in vivo mapping of acetylcholinesterase Choe YS, Oh S, Shim I, Naruto S, Chi DY, Kim SE, Lee K, Choi Y, Kim B Ref: Nucl Med Biol, 27:263, 2000 : PubMed
We synthesized novel (18)F-labeled acetylcholinesterase (AChE) inhibitors, 3-[1-(3- and 4-[(18)F]fluoromethylbenzyl)piperidin-4-yl]-1-(1-methyl-1H-i ndol-3-yl )propan-1-ones ([(18)F]1 and [(18)F]2) and 3-[1-(4-[(18)F]fluorobenzyl)piperidin-4-yl]-1-(1-methyl-1H-i ndol-3-yl )propan-1-one ([(18)F]3) in high yields (decay-corrected, 25%-40%) and with high effective specific activities (>37 GBq/micromol). Tissue distribution studies of the [(18)F]1 and the [(18)F]3 in mice showed the nonspecific bindings in brain regions, with metabolic defluorination of the [(18)F]1. The result suggests that these radioligands may not be suitable agents for in vivo mapping of AChE, despite their potent in vitro anti-AChE activities.
        
Related information
Citations formats
Choe YS, Oh S, Shim I, Naruto S, Chi DY, Kim SE, Lee K, Choi Y, Kim B (2000) Syntheses and biological evaluation of (18)F-labeled 3-(1-benzyl-piperidin-4-yl)-1-(1-methyl-1H-indol-3-yl)propan-1-ones for in vivo mapping of acetylcholinesterase Nucl Med Biol27: 263-7
Choe YS, Oh S, Shim I, Naruto S, Chi DY, Kim SE, Lee K, Choi Y, Kim B (2000) Nucl Med Biol27: 263-7